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of Family Group Practitioners, the 
Association of Hospitals, and the 
Medical Accreditation Commission 
in Kyrgyzstan. Their role has included 
reorganisation of service delivery, 
new provider payment mechanisms, 
and new forms of accounting and 
reporting. These associations are highly 
dependent on donor assistance for 
their survival, but they have shown the 
ability to be efficient partners to the 
government in reforming health care 
and other issues related to regulation 
of medical practice and delivery of 
public services. This work highlights the 
importance of such organisations in 
improving health-care delivery, but also 
how associations can be used to address 
speciﬁ c needs in a given context. Clearly 
much has to be done to help with the 
development of PMAs in low-income 
and middle-income countries, opening 
up the need for WHO and the World 
Medical Association to invest in this 
area of the health system. An approach 
to develop PMAs in low-income 
and middle-income countries could 
be through twinning programmes8 
between medical associations in these 
settings  and high-income settings. 
PMAs play a crucial role in shaping 
human resources for health, one of the 
six building blocks of the health system, 
but have yet to be supported and fully 
used in low-income and middle-income 
settings for the beneﬁ t of the health of 
the populations they serve.
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From a historical perspective, 
Professional Medical Associations 
(PMAs) were developed as groups 
with a shared scientific interest or 
established by the authorities to act 
as a regulatory body.1 PMAs have 
diﬀ erent roles based on which country 
they are located in and the health-
care system in which they operate. 
PMAs can be involved in: education 
and training including Continuing 
Medical Education (CME), licensing, 
regulation, ethical issues, setting 
standards including clinical guidelines, 
and representing doctors interests.2 
With regards to education, PMAs can 
be responsible for diﬀ erent areas of 
educational standards, such as the 
undergraduate curriculum in medical 
schools, postgraduate medical 
education in terms of internship 
and residency training, and CME.3 
Additionally, they might be involved 
in examinations and within this role 
confer certiﬁ cation of qualiﬁ cations. 
Many PMAs also develop codes 
of ethics as guides to help in solving 
problems that doctors could be faced 
with in their practice of medicine,4,5 
but also issues of conﬂ ict of interest 
with the pharmaceutical industry. 
For example, the European Society 
of Cardiology5 discusses how all 
promotional and educational 
activities supported by the industry 
need to comply with regulations 
developed by the European Federation 
of Pharmaceutical Industries and 
Associations and the International 
Federation of Pharmaceutical 
Manufacturers Associations as well as 
any national regulations that may exist. 
Given this responsibility PMAs play a 
crucial part in health reforms globally.6,7 
Despite these important roles, little 
research has been done on PMAs 
in low-income and middle-income 
countries. Recent work (2015–16) in 
Kyrgyzstan found that very few PMAs 
were active in many of the diﬀ erent key 
areas described above. In Kyrgyzstan 
there was a legal framework for the 
creation and the function of PMAs, 
but because of a scarcity in resources 
these associations are often unable to 
accomplish their stated responsibilities 
to their membership, the Ministry of 
Health, and the country. 
One of the main barriers for PMAs 
in Kyrgyzstan was a shortage of funds. 
This shortage was due to a lack of clear 
benefits for members, leading to a 
vicious cycle since a lack of beneﬁ ts 
means less income and less income 
means an inability to provide more 
benefits. This shortage of income 
from membership fees meant that 
PMAs needed to get funding from 
pharmaceutical companies. It was 
found that this was not encompassed 
by any ethical standards, leading to 
questions about possible conflict 
of interests.
PMAs in Kyrgyzstan clearly have a 
part to play in view of the expertise 
of their members. However, besides 
the scarcity of resources available, 
there is also the lack of vision from the 
Ministry of Health, the health system, 
and doctors as to what the function 
and responsibilities of a medical 
association should be. To transform 
this view requires a change in 
professional culture, in which doctors 
have to take the initiative to move 
the role of their profession forward to 
improve the health of the populations 
they serve. Expertise in Kyrgyzstan 
is often concentrated, with many 
individuals wearing multiple “hats” 
such as national experts, clinicians, 
teachers, and advisers. These experts 
give advice, produce guidelines, and 
provide training for all doctors of a 
given specialty. 
An interesting lesson from 
Kyrgyzstan is the creation of specific 
associations by donors to assist with 
health-system reforms. The reforms 
in the health sector generated the 
need to create non-governmental 
organisations, such as the Association 
Correspondence
e607 www.thelancet.com/lancetgh   Vol 4   September 2016
 1 Pellegrino ED, Relman AS. Professional medical 
associations: ethical and practical guidelines. 
JAMA 1999; 282: 984–86.
 2 Borow M, Levi B, Glekin M. Regulatory tasks of 
national medical associations—international 
comparison and the Israeli case. 
Isr J Health Policy Res 2013; 2: 8.
 3 Blackmer J. Professionalism and the Medical 
Association. Ferney-Voltaire: World Medical 
Association, 2007.
 4 Linker B. The business of ethics: gender, 
medicine, and the professional codiﬁ cation of 
the American Physiotherapy Association, 
1918–1935. J Hist Med Allied Sci 2005; 
60: 320–54.
 5 ESC Board. Relations between professional 
medical associations and healthcare industry, 
concerning scientiﬁ c communication and 
continuing medical education: a policy 
statement from the European Society of 
Cardiology. Rev Port Cardiol 2012; 31: 529–38.
 6 Yamey G. Scaling up global health 
interventions: a proposed framework for 
success. PLoS Med 2011; 8: e1001049.
 7 Hongoro C, Kumaranayake L. Do they work? 
Regulating for-proﬁ t providers in Zimbabwe. 
Health Policy Plan 2000; 15: 368–77.
 8 Yudkin JS, Holt RI, Silva-Matos C, Beran D. 
Twinning for better diabetes care: a model for 
improving healthcare for non-communicable 
diseases in resource-poor countries. 
Postgrad Med J 2009; 85: 1–2.
